We found that PIK3CA tended to mutate in patients whose tumor was located in the lower-third (7/10), classified as intestinal-type GC (6/10), and undifferentiated GC (6/10); however, there was no significant difference in frequency compared to other mutant patients. Here, PIK3CA is linked to neoplasm.